Previously Rejected Drug Approved as First Barth Syndrome Treatment

(MedPage Today) — The FDA on Friday granted accelerated approval to elamipretide (Forzinity) as the first treatment for the ultra-rare Barth syndrome, which affects approximately 150 Americans.
Elamipretide once-daily injections are now indicated…